Paper
CD10 enhances metastasis of colorectal cancer by abrogating the antitumoral effect of methionine-enkephalin in the liver
1 Nara Medical University, Japan;
2 Miyoshi Central Hospital, Japan;
3 Fukuoka University, Japan
Correspondence to: Hiroki Kuniyasu, Molecular Pathology, NARA MEDICAL UNIVERSITY, Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, 634-8521, Japan; cooninh{at}zb4.so-net.ne.jp
Accepted 16 September 2009
Objective: To examine the role of CD10, a characteristic marker of liver metastasis of colorectal cancers (CRCs).
Design: The effect of CD10 and Met-enkephalin (MENK) in CD10-positive and -negative human CRC cells was investigated under in vitro and in vivo conditions. Human CRC samples were examined.
Main outcome measure: CD10-positive and CD10-knockdown HT29 cells and CD10-negative and CD10-transfected Colo320 cells in nude mice were treated with MENK and/or the CD10 inhibitor (thiorphan). Intracellular signaling of MENK and
Ô-opioid receptor (DOR) was examined by immunoblotting.
Results: MENK inhibited the growth, invasion, and survival of CRC cells following thiorphan-induced CD10 inactivation. Thiorphan suppressed liver metastasis of CD10-positive CRC cells. Inoculation of mice with CRC cells induced MENK expression in the liver. Inhibition of hepatic MENK expression by cholesterol-conjugated antisense S-oligodeoxynucleotide increased liver metastasis of CRC cells even when the cells did not express CD10. DOR activation by MENK decreased the phosphorylation of epidermal growth factor receptor and extracellular signal-regulated kinase and increased p38-dependent apoptosis. Nitric oxide was found to induce DOR expression in CRC cells. Co-treatment with thiorphan and a nitric oxide donor had a marked antitumor effect on liver metastasis of HT29 cells. Of 68 CRC patients, 19 (28%) showed CD10 expression, which was dependent on the extent of liver metastasis. MENK concentration in metastasis-positive human liver was higher than that in the normal liver.
Conclusion: CD10 expression in CRC cells abrogates the antitumor effect of hepatic MENK by degrading it, which enhances liver metastasis of CD10-positive CRC cells.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
